glutathione disulfide has been researched along with deoxyglucose in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andringa, KK; Aykin-Burns, N; Coleman, MC; Domann, FE; Hitchler, MJ; Spitz, DR; Walsh, SA | 1 |
Aykin-Burns, N; Diers, AR; Fath, MA; Hua, L; Simons, AL; Spitz, DR | 1 |
Almasan, A; Boutros, J | 1 |
Gius, D; Mapuskar, KA; Mattson, DM; Scarbrough, PM; Spitz, DR; Watson, WH | 1 |
4 other study(ies) available for glutathione disulfide and deoxyglucose
Article | Year |
---|---|
Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buthionine Sulfoximine; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Glutathione Disulfide; Humans; Oxidative Stress; RNA, Messenger | 2006 |
Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells.
Topics: Animals; Antimycin A; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Colonic Neoplasms; Deoxyglucose; Drug Synergism; Electron Transport; Fibroblasts; Glutathione; Glutathione Disulfide; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, Nude; Mitochondria; Oxidation-Reduction; Oxidative Stress; Rotenone; Tumor Burden; Uncoupling Agents; Xenograft Model Antitumor Assays | 2009 |
Combining 2-deoxy-D-glucose with electron transport chain blockers: a double-edged sword.
Topics: Animals; Antimycin A; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colonic Neoplasms; Deoxyglucose; Drug Synergism; Electron Transport; Glutathione; Glutathione Disulfide; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, Nude; Mitochondria; Oxidation-Reduction; Oxidative Stress; Rotenone; Tumor Burden; Uncoupling Agents; Xenograft Model Antitumor Assays | 2009 |
Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
Topics: Antineoplastic Agents; Auranofin; Benzoquinones; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Deoxyglucose; Drug Synergism; Glutamate-Cysteine Ligase; Glutathione; Glutathione Disulfide; Humans; Lactams, Macrocyclic; Oxidation-Reduction; Oxidative Stress; Thioredoxin-Disulfide Reductase; Thioredoxins | 2012 |